Britain's Drug Authority Okays Full-Scale Patient Cannabis Trials 4/7/00

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


(courtesy NORML Foundation,

London, England:  Britain's Medicines Control Agency has given approval to GW Pharmaceuticals for human medical marijuana trials.

This study is the first full-scale patient trial of therapeutic cannabis products and will involve 2,000 patients.  Patients suffering from multiple sclerosis, spinal cord injury, severe pain and spasticity will be involved in the trials.

"Our aim is to test some of the claims which have been made for the medicinal qualities of cannabis in a structured clinical research program," said Dr. Willy Notcutt who leads this first trial.  "This is an exciting moment, and we hope very much that our findings will lead to significant improvements in the pain relief available for sufferers of multiple sclerosis and other debilitating conditions."

"It's remarkable that the British government has moved so quickly on the matter of conducting actual human trials with marijuana," said Allen St. Pierre, NORML Foundation Executive Director.  "The British have gone from white paper to parliamentary report to research implementation in less than two years.  Compare that with the US, where, in the last 30 years the government has fought 'tooth and nail' to not allow medical access to marijuana."

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #132, 4/7/00 AlertS: Colombia, New York State, HEA Reform | Penn State Student Government Endorses HEA Reform, Campaign Grows | CALIFORNIA: Santa Cruz Passes Ordinance Protecting Medical Marijuana Users | Another Zero-Tolerance Message Issued and Received | UK: Police Foundation Report Stirs Debate | Britain's Drug Authority Okays Full-Scale Patient Cannabis Trials | More "Propaganda for Dollars" Exposed by Dan Forbes and, Salon Offering Drug War "Theme Park" on Web | LEGALIZACION: The L-Word Enters Post-Certification Debate in Mexico | NEWSBRIEF: US Anti-Drug Colonel Pleads Guilty | Follow-up to Sylvester Salcedo Interview | No Editorial This Week
Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]